These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35256687)

  • 1. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
    Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
    Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.
    Mendiola M; Saarela J; Escudero FJ; Heredia-Soto V; Potdar S; Rodriguez-Marrero S; Miguel M; Pozo-Kreilinger JJ; Berjon A; Ortiz-Cruz E; Feliu J; Redondo A
    Biomed Pharmacother; 2024 Apr; 173():116397. PubMed ID: 38479181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.
    Vannini A; Parenti F; Forghieri C; Barboni C; Zaghini A; Campadelli-Fiume G; Gianni T
    Front Mol Biosci; 2023; 10():1149973. PubMed ID: 37251078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immune pathobiology of human angiosarcoma.
    Lim RMH; Lee JY; Kannan B; Ko TK; Chan JY
    Biochim Biophys Acta Rev Cancer; 2024 Jul; ():189159. PubMed ID: 39032539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiosarcoma of the Heart.
    Göbölös L; Bhatnagar G
    JACC Case Rep; 2021 Jun; 3(6):950-953. PubMed ID: 34317663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and functional characterization of the oncogenicity and targetability of a novel
    Jain P; Iyer S; Straka J; Surrey LF; Pogoriler J; Han H; Smith T; Busch C; Fox E; Li M; Waanders AJ; Resnick A; Davare MA
    Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
    Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
    Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nail Apparatus Melanoma: Current Management and Future Perspectives.
    Ito T; Hashimoto H; Kaku-Ito Y; Tanaka Y; Nakahara T
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nectins and Nectin-like molecules drive vascular development and barrier function.
    Hermans D; Rodriguez-Mogeda C; Kemps H; Bronckaers A; de Vries HE; Broux B
    Angiogenesis; 2023 Aug; 26(3):349-362. PubMed ID: 36867287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma.
    Tanaka Y; Ito T; Kaku-Ito Y; Tanegashima K; Tsuji G; Kido-Nakahara M; Oda Y; Nakahara T
    Cell Death Discov; 2023 Feb; 9(1):54. PubMed ID: 36765036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nectin4 is a potential therapeutic target for asthma.
    Lee PH; Choi SM; An MH; Hwang DY; Park S; Baek AR; Jang AS
    Front Immunol; 2022; 13():1049900. PubMed ID: 36457999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NECTIN4: A Novel Therapeutic Target for Melanoma.
    Tanaka Y; Murata M; Shen CH; Furue M; Ito T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
    Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
    Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
    Tanaka Y; Murata M; Oda Y; Furue M; Ito T
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Nectin‑4 protein in cancer (Review).
    Liu Y; Han X; Li L; Zhang Y; Huang X; Li G; Xu C; Yin M; Zhou P; Shi F; Liu X; Zhang Y; Wang G
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34664682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment.
    Khan JA; Maki RG; Ravi V
    J Clin Oncol; 2018 Jan; 36(2):194-201. PubMed ID: 29220293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma.
    Tanaka Y; Murata M; Tanegashima K; Oda Y; Ito T
    Sci Rep; 2022 Mar; 12(1):4031. PubMed ID: 35256687
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.